HOME >> MEDICINE >> NEWS
Mayo Clinic discovers 'new pathway' against pancreatic cancer

ROCHESTER, Minn. -- Pancreatic cancer kills 30,000 Americans every year. Not only is there no cure, but there are no effective treatments. That may change if a new finding by Mayo Clinic researchers continues to show promise. In the March 15 issue of the journal Cancer Research, (http://cancerres.aacrjournals.org/future/65.6.shtml) investigators describe discovering a key molecule that controls the growth, spread and survival of pancreatic cancer cells. This is a critical first step toward developing new and better treatments for patients with pancreatic cancer.

"This is a very exciting -- and surprising -- finding," says Daniel Billadeau, Ph.D., lead author of the report. To identify new target molecules with potentially therapeutic impact for a cancer for which there is currently no real useful treatment is incredibly important.

"Based on the literature, you would predict the opposite of what we found. But in fact, we determined that we can decrease a known regulator of cancer cell survival -- in effect, turn this regulator off -- and when we do, the pancreatic cancer cells undergo apoptosis (commit cell suicide) and die."

Significance of the Research

  • With this finding, a new path is cleared for researchers to target these key molecular players with new small molecule inhibitors to block their action, effectively turning off molecules that promote pancreatic cancer growth.

  • The finding may be applied to make pancreatic cells more sensitive to gemcitabine, the sole drug available for treating pancreatic cancer.

  • This discovery may lead to new drug development strategies for other cancers. Additional research will tell whether these same actors play a similar role in the spread of other cancer types.

    The Key Finding

    The Mayo Clinic researchers discovered a previously unrecognized role in pancreatic cancer for
    '"/>



  • Contact: Bob Nellis
    newsbureau@mayo.edu
    507-284-5005
    Mayo Clinic
    15-Mar-2005


    Page: 1 2

    Related medicine news :

    1. Mayo Clinic develops first genomic-based test to predict stroke from ruptured brain aneurysm
    2. Mayo Clinic study sets threshold for valve repair surgery
    3. Mayo Clinic researcher calls for improved newborn screening
    4. Mayo Clinic study finds obese kidney donors face few increased risks
    5. Mayo Clinic identifies key cellular process in prostate and other cancers
    6. Clinical breast examination offers modest benefit to breast cancer screening program
    7. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
    8. Clinicians report missing patient information is common
    9. Mayo Clinic discovers a key to low metabolism and major factor in obesity
    10. Clinical trial of Etanercept for Wegeners disease shows no benefit
    11. Mayo Clinic researchers identify new form of muscular dystrophy in adults

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:3/20/2019)... SAN JOSE, Calif. (PRWEB) , ... March 20, ... ... safety net health plan for Santa Clara County, announced that the National Committee ... Cal MediConnect (Medicare-Medicaid Plan) line of business. NCQA is a private, not-for-profit organization ...
    (Date:3/20/2019)... ... 20, 2019 , ... TSI Healthcare, a national ... Electronic Health Record (EHR) solutions, received multiple top awards in the 2019 ... consecutive year TSI Healthcare has been honored by this selective international organization. In ...
    (Date:3/20/2019)... ... 20, 2019 , ... EBSCO Health , the leading ... announced the certification of two decision aids by the Washington State Health Care ... Test: Yes or No? Currently, Washington is the only state requiring certification for ...
    (Date:3/20/2019)... ... 2019 , ... The American Board of Family Medicine (ABFM) ... for ABFM Diplomates. The new website, available at http://www.theabfm.org , is designed ... a responsive design, providing functional access from a desktop, a tablet, or smartphone, ...
    (Date:3/20/2019)... ... March 20, 2019 , ... Natreon has been ... of trivalent chromium chloride combined with extracts of amla and shilajit, that has ... patent, along with 7 clinical studies on Crominex®3+, establish this ingredient as the ...
    Breaking Medicine News(10 mins):
    (Date:3/20/2019)... ... March 20, 2019 , ... ... services and products, announced today that it has partnered with ZRx Outcomes ... company offers RWE research, systematic literature review, comparative effectiveness research (CER), decision ...
    (Date:3/20/2019)... ... March 20, 2019 , ... NDA Partners Chairman ... with extensive experience in the development of generic drugs and drug/device combination products at ... as an Expert Consultant. , During his career with FDA, Mr. Gonitzke served as ...
    (Date:3/19/2019)... ... 2019 , ... TreTap Launches First-Ever CBD Infused Organic Tree Water Beverage , ... winner will receive TreTap beverages for a year , One of Vermont’s fastest ... Tretap, which was acquired by Vermont’s original CBD store - Ceres Natural Remedies - ...
    Breaking Medicine Technology:
    Cached News: